Retatrutide vs. Semaglutide vs. Tirzepatide: Comparing GLP-1 Class Peptides
The incretin-based peptide research field has expanded rapidly over the past several years, moving from single-receptor compounds to increasingly sophisticated multi-receptor agonists. Semaglutide, tirzepatide, and retatrutide represent three successive generations of this progression, each engaging a different combination of metabolic receptors. Understanding how they differ mechanistically is essential for interpreting comparative research — including outcome […]


















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































